DNA

Ginkgo Bioworks Holdings Inc

Halal Rating :
Comfortable
Last Price $9.99 Last updated:
Market Cap $371.8m
7D Change 3.95%
1 Year Change 458.1%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NYSE
Next Earnings Date Nov. 6, 2024

Ginkgo Bioworks Holdings Inc is a biotechnology company that specializes in using genetic engineering to produce bacteria with industrial applications. The company designs and prints DNA sequences, engineers cells, and develops software for genetic engineering applications. Their platform is used across various industries including pharmaceuticals, agriculture, and materials production.

The company provides cell programming services to help customers optimize production of various compounds through biological processes. Their technology enables the development of organisms that can produce valuable chemicals, materials, and other products more efficiently and sustainably than traditional methods.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $89.05m $144.25m - - 0.00% 0.00%
June 30, 2024 $56.21m $268.84m - $-10313000.0 0.00% 3.84%
March 31, 2024 $37.94m $204.24m - $-11711000.0 0.00% 5.73%

Company Impact

Help us evaluate Ginkgo Bioworks Holdings Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates